Lung Cancer

March 25, 2015March 25, 2015

Specialists Call on UN and WHO to Help End Tobacco Use by 2040

Lung Cancer, News

A group of international specialists in respiratory health are joining efforts to advocate for a phased termination of tobacco selling by 2040, as well as requesting governments to engage in the process by ... Read more

March 24, 2015March 24, 2015

Clinical Trial Finds Early Recall Rates Decline After Second Round Of Lung Cancer Screening

Lung Cancer, News

The International Association for the Study of Lung Cancer (IASLC) reports that in the U.S., the National Lung Cancer Screening Trial (NLST) demonstrated that annual screening of high-risk individuals with ... Read more

March 20, 2015March 20, 2015

Nashville Residents Join LUNG FORCE Walk Against Lung Cancer

Lung Cancer, News

Residents in Nashville are joining the LUNG FORCE WALK to do their part in the ongoing fight against lung cancer. More than 105,000 American women will receive a lung cancer diagnosis in ... Read more

March 18, 2015March 18, 2015

CDC Report Reveals Lung Cancer Ranks Third Most Common

Lung Cancer, News

Lung and bronchus cancers rank third among the world’s more common types of cancers, according to the latest Morbidity and Mortality Weekly Report released by the Centers for Disease Control and Prevention (CDC), which analyzed cancer ... Read more

March 17, 2015March 17, 2015

Biodesix and Inivata Partner Against Lung Cancer Through Development of TAm-Seq™ Technology Platform

Lung Cancer, News

Biodesix, Inc. and Inivata recently announced a partnership to advance and commercialize Next Generation Sequencing (NGS) tests (blood tests) that might have clinical applications for lung cancer. This agreement will help further develop the TAm-Seq™ technology ... Read more

March 13, 2015March 13, 2015

Biocept Expands Non-Small Cell Lung Cancer Diagnostic Capabilities To Address EGFR Mutations

Lung Cancer, News

Biocept, Inc., a molecular oncology diagnostics company dedicated to biomarker analysis of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) has recently announced the launch of the company’s EGFR ... Read more

March 11, 2015March 11, 2015

Zykadia by Novartis Recommended For EU Approval To Treat ALK+ NSCLC Patients Previously Treated With Crizotinib

Lung Cancer, News

Zykadia from Novartis was recommended for EU approval to address treatment for adult patients suffering from anapestic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC), also known as ALK+NSCLC, which has been treated previously with crizotinib. If ... Read more

March 10, 2015March 10, 2015

Targeted Lung Cancer Therapies Are Replacing Conventional Treatments

Lung Cancer, News

As the market for lung cancer therapeutics continues to grow, drug manufacturers are competing to find their own niches. Approximately 130 drugs to address small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) are currently ... Read more

March 9, 2015March 9, 2015

FDA Approves Nivolumab for the Treatment of Metastatic Squamous Non-small Cell Lung Cancer

Lung Cancer, News

The U.S. Food and Drug Administration recently approved the medication nivolumab (Opdivo; Bristol-Myers Squibb Company) as a therapy for patients with metastatic squamous non-small cell lung cancer (NSCLC) with progression on ... Read more

March 2, 2015March 2, 2015

Ancon Medical Creates Lung Cancer Breath Test

Lung Cancer, News

American medical device maker Ancon Medical Inc., recently developed an innovative new breath screening technology that allows clinicians to easily detect biomarkers for dangerous and deadly diseases at their earliest stages. The Nanoparticle Biomarker Tagging ... Read more